Related Experiment Video
Updated: Oct 1, 2025

An In Vitro Bladder Model of Catheter-Associated Urinary Tract Infection
Published on: June 24, 2025
Targeting Microbial Bio-film: an Update on MDR Gram-Negative Bio-film Producers Causing Catheter-Associated Urinary
Susmita Chakrabarty1, Monali P Mishra2, Dipankar Bhattacharyay3
1School of Paramedics and Allied Health Sciences, Centurion University of Technology and Management, Sitapur, Odisha, India.
Urinary tract infections (UTIs) often recur due to biofilm-producing, multidrug-resistant (MDR) Gram-negative bacteria. This review explores their mechanisms, challenges in treating catheter-associated UTIs, and potential anti-biofilm therapies.
Area of Science:
- Microbiology
- Infectious Diseases
- Urology
Background:
- Urinary tract infections (UTIs) are a significant cause of recurrent infectious disease across all age groups.
- Bacterial biofilms play a crucial role in the pathogenesis of UTIs, leading to persistent infections, recurrences, and relapses.
- Catheter-associated UTIs (CAUTIs) represent a major challenge in healthcare settings.
Purpose of the Study:
- To review the role and mechanisms of biofilm-producing multidrug-resistant (MDR) Gram-negative bacteria in causing UTIs.
- To highlight the significance of these bacteria and the challenges in treating and preventing CAUTIs.
- To explore novel strategies targeting biofilms and discuss phytochemicals with anti-biofilm activity.
Main Methods:
- Literature review focusing on biofilm formation by uropathogenic bacteria.
- Analysis of MDR Gram-negative bacteria associated with UTIs and CAUTIs.
- Compilation of data on anti-biofilm approaches and phytochemical interventions.
Main Results:
- Biofilm production by MDR Gram-negative bacteria is a key factor in recurrent and persistent UTIs, particularly CAUTIs.
- Understanding biofilm mechanisms is essential for developing effective treatment and prevention strategies.
- Phytochemicals show promise as potential agents against biofilm formation.
Conclusions:
- Targeting bacterial biofilms is critical for managing recurrent UTIs and CAUTIs.
- Further research into anti-biofilm therapies, including phytochemicals, is warranted.
- Effective control of biofilm-producing uropathogenic bacteria is necessary to improve patient outcomes.
Related Concept Videos
Biofilms
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Gene Regulation in Microbial Communities: Quorum Sensing
Urinary Tract Infection II: Pathophysiology

